Allscripts Healthcare Solutions, Inc(PINK:MDRX) 
Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, out...
Website: http://www.allscripts.com
Founded: 1986
Full Time Employees: 9,600
Sector: Healthcare
Industry: Health Information Services
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2024-12-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-05-31 | 2010-02-28 | 2009-11-30 | 2009-08-31 | 2009-05-31 | 2009-02-28 | 2008-11-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 |
|---|
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-05-31 | 2010-02-28 | 2009-11-30 | 2009-08-31 | 2009-05-31 | 2009-02-28 | 2008-11-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 492,597,000 | 500,164,000 | 82,782,000 | 188,351,000 | 214,179,000 | 229,254,000 | 513,400,000 | 531,104,000 | 218,701,000 | 199,004,000 | 204,308,000 | 129,668,000 | 129,349,000 | 138,903,000 | 137,167,000 | 174,243,000 | 111,775,000 | 135,851,000 | 135,003,000 | 155,839,000 | 104,301,000 | 82,714,000 | 104,391,000 | 96,610,000 | 77,251,000 | 90,655,000 | 100,116,000 | 116,873,000 | 91,398,000 | 76,537,000 | 88,480,000 | 53,173,000 | 37,345,000 | 39,250,000 | 41,580,000 | 62,954,000 | 60,790,000 | 71,984,000 | 92,228,000 | 103,956,000 | 93,672,000 | 120,373,000 | 175,680,000 | 157,753,000 | 84,778,000 | 115,671,000 | 145,446,000 | 120,067,000 | 143,410,000 | 115,757,000 | 88,646,000 | 84,849,000 | 71,159,000 | 69,859,000 | 68,890,000 | 71,189,000 | 50,844,000 | 43,721,000 | 43,785,000 | 31,968,000 | 40,376,000 | 44,221,000 | 42,461,000 | 35,734,000 | 32,978,000 | 35,225,000 | 60,905,000 | 37,719,000 | 36,779,000 | 25,262,000 | 16,972,000 | 47,328,000 | 18,339,000 | 12,004,000 | 13,336,000 | 10,496,000 |
restricted cash | 1,307,000 | 1,307,000 | 1,305,000 | 2,169,000 | 2,141,000 | 2,129,000 | 2,110,000 | 6,361,000 | 6,209,000 | 6,194,000 | 7,824,000 | 7,871,000 | 9,375,000 | 9,236,000 | 10,681,000 | 10,552,000 | 8,016,000 | 4,925,000 | 8,769,000 | 6,659,000 | 5,123,000 | 6,400,000 | 2,225,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | 169,029,000 | 166,746,000 | 170,497,000 | 327,069,000 | 340,924,000 | 338,587,000 | 359,068,000 | 347,355,000 | 381,888,000 | 415,848,000 | 471,213,000 | 459,751,000 | 426,579,000 | 428,085,000 | 457,960,000 | 465,264,000 | 520,381,000 | 522,144,000 | 495,695,000 | 567,873,000 | 442,872,000 | 420,116,000 | 414,613,000 | 405,172,000 | 400,101,000 | 395,629,000 | 340,091,000 | 327,851,000 | 324,552,000 | 323,486,000 | 325,237,000 | 331,625,000 | 340,696,000 | 336,846,000 | 341,591,000 | 313,486,000 | 322,342,000 | 346,417,000 | 351,772,000 | 337,024,000 | 371,322,000 | 363,050,000 | 370,022,000 | 362,793,000 | 371,182,000 | 356,938,000 | 320,433,000 | 308,377,000 | 181,920,000 | 179,169,000 | 154,951,000 | 150,335,000 | 155,122,000 | 167,966,000 | 148,038,000 | 95,560,000 | 83,847,000 | 80,997,000 | 81,351,000 | 81,225,000 | 69,610,000 | 57,380,000 | 55,579,000 | 57,394,000 | 44,610,000 | 43,366,000 | 29,244,000 | 26,765,000 | 23,323,000 | 23,278,000 | 21,382,000 | 20,441,000 | 18,898,000 | 17,255,000 | 18,219,000 | 15,796,000 |
contract assets, net of allowance of 564 and 576 as of september 30, 2022 and december 31, 2021, respectively | 65,453,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | 74,384,000 | 91,521,000 | 56,191,000 | 118,942,000 | 124,473,000 | 150,968,000 | 128,493,000 | 136,264,000 | 135,869,000 | 149,080,000 | 125,677,000 | 147,990,000 | 142,843,000 | 152,476,000 | 133,448,000 | 142,455,000 | 131,826,000 | 128,325,000 | 130,051,000 | 115,463,000 | 115,701,000 | 113,563,000 | 108,157,000 | 102,551,000 | 112,416,000 | 107,810,000 | 99,127,000 | 93,622,000 | 98,511,000 | 104,314,000 | 108,020,000 | 102,398,000 | 115,212,000 | 110,967,000 | 103,218,000 | 107,911,000 | 117,051,000 | 120,102,000 | 118,343,000 | 110,023,000 | 124,494,000 | 130,099,000 | 129,413,000 | 117,444,000 | 103,277,000 | 100,801,000 | 99,435,000 | 100,642,000 | 50,598,000 | 47,602,000 | 41,553,000 | 36,492,000 | 31,061,000 | 30,047,000 | 31,821,000 | 17,947,000 | 17,582,000 | 19,534,000 | 17,401,000 | 16,920,000 | 15,021,000 | 12,980,000 | 10,620,000 | 9,106,000 | 6,800,000 | 6,877,000 | 5,811,000 | 4,889,000 | 3,733,000 | 3,815,000 | 3,571,000 | 3,215,000 | 2,488,000 | 2,836,000 | 3,863,000 | |
current assets attributable to discontinued operations | 8,000,000 | 20,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total current assets | 810,770,000 | 828,767,000 | 1,540,684,000 | 761,342,000 | 804,961,000 | 840,989,000 | 1,135,437,000 | 1,153,222,000 | 948,782,000 | 869,801,000 | 907,193,000 | 841,262,000 | 773,661,000 | 804,051,000 | 834,333,000 | 858,965,000 | 843,743,000 | 855,664,000 | 911,064,000 | 845,834,000 | 667,997,000 | 622,793,000 | 627,161,000 | 604,333,000 | 589,768,000 | 594,094,000 | 539,334,000 | 538,346,000 | 550,197,000 | 540,142,000 | 557,388,000 | 522,811,000 | 548,711,000 | 542,508,000 | 541,855,000 | 539,819,000 | 555,691,000 | 594,011,000 | 619,301,000 | 607,502,000 | 631,816,000 | 655,391,000 | 718,406,000 | 680,649,000 | 593,308,000 | 608,453,000 | 598,623,000 | 550,160,000 | 408,154,000 | 347,818,000 | 290,556,000 | 275,487,000 | 260,977,000 | 285,125,000 | 267,114,000 | 200,783,000 | 176,438,000 | 178,448,000 | 169,124,000 | 187,258,000 | 182,727,000 | 169,375,000 | 153,897,000 | 120,776,000 | 109,341,000 | 110,619,000 | 153,044,000 | 128,780,000 | 111,249,000 | 89,189,000 | 67,720,000 | 89,018,000 | 48,185,000 | 39,414,000 | 42,339,000 | 39,938,000 |
fixed assets | 11,713,000 | 14,971,000 | 9,299,000 | 47,902,000 | 53,667,000 | 59,077,000 | 67,376,000 | 72,162,000 | 70,027,000 | 75,728,000 | 81,830,000 | 88,339,000 | 96,813,000 | 105,923,000 | 115,564,000 | 121,913,000 | 160,225,000 | 160,585,000 | 164,878,000 | 165,603,000 | 165,434,000 | 160,470,000 | 153,197,000 | 148,810,000 | 144,804,000 | 143,731,000 | 117,679,000 | 125,617,000 | 127,739,000 | 135,542,000 | 140,116,000 | 145,830,000 | 152,213,000 | 163,128,000 | 168,026,000 | 174,013,000 | 166,579,000 | 170,950,000 | 162,318,000 | 155,494,000 | 143,823,000 | 139,233,000 | 134,364,000 | 122,563,000 | 102,877,000 | 99,089,000 | 117,913,000 | 101,623,000 | 24,637,000 | 19,534,000 | 18,366,000 | 17,477,000 | 17,343,000 | 20,297,000 | 21,147,000 | 21,209,000 | 18,238,000 | 16,662,000 | 17,111,000 | 15,129,000 | 14,094,000 | 2,753,000 | 2,597,000 | 2,482,000 | 2,423,000 | 2,366,000 | 2,180,000 | 2,204,000 | 2,117,000 | 2,237,000 | 2,566,000 | |||||
software development costs | 78,103,000 | 82,541,000 | 78,334,000 | 172,104,000 | 176,721,000 | 182,848,000 | 188,716,000 | 193,202,000 | 241,656,000 | 253,442,000 | 250,412,000 | 243,929,000 | 236,551,000 | 225,646,000 | 219,047,000 | 209,660,000 | 239,359,000 | 225,251,000 | 235,845,000 | 222,189,000 | 207,055,000 | 192,920,000 | 175,371,000 | 163,879,000 | 140,025,000 | 97,646,000 | 86,113,000 | 85,775,000 | 82,249,000 | 83,668,000 | 83,485,000 | 86,153,000 | 85,018,000 | 81,373,000 | 85,177,000 | 88,244,000 | 89,226,000 | 90,521,000 | 92,909,000 | 95,579,000 | 105,479,000 | 108,789,000 | 103,879,000 | 98,378,000 | 91,504,000 | 81,903,000 | 73,671,000 | 45,008,000 | 29,900,000 | 23,791,000 | 20,151,000 | 16,381,000 | 13,515,000 | 7,662,000 | 2,306,000 | 22,951,000 | 25,833,000 | 25,509,000 | 24,115,000 | 19,720,000 | 18,540,000 | 15,871,000 | 12,285,000 | 9,987,000 | 8,176,000 | 6,777,000 | 6,409,000 | 6,423,000 | 6,181,000 | 6,155,000 | 6,270,000 | 6,408,000 | 5,830,000 | 5,043,000 | 4,040,000 | 3,070,000 |
intangible assets | 145,255,000 | 149,210,000 | 158,285,000 | 235,930,000 | 248,408,000 | 261,258,000 | 273,927,000 | 286,602,000 | 329,011,000 | 343,636,000 | 358,309,000 | 374,142,000 | 397,950,000 | 402,783,000 | 415,437,000 | 431,081,000 | 873,635,000 | 839,173,000 | 827,059,000 | 826,872,000 | 717,233,000 | 698,950,000 | 720,417,000 | 741,403,000 | 730,775,000 | 715,701,000 | 335,722,000 | 347,646,000 | 360,929,000 | 378,358,000 | 387,047,000 | 403,362,000 | 422,192,000 | 426,171,000 | 442,053,000 | 455,971,000 | 471,758,000 | 488,184,000 | 504,126,000 | 426,986,000 | 442,381,000 | 457,725,000 | 473,786,000 | 489,848,000 | 505,928,000 | 522,156,000 | 538,384,000 | 558,721,000 | 206,642,000 | 211,896,000 | 217,150,000 | 222,437,000 | 227,766,000 | 238,670,000 | 244,413,000 | 96,983,000 | 100,638,000 | 104,070,000 | 107,503,000 | 74,717,000 | 72,927,000 | 75,488,000 | 78,050,000 | 80,611,000 | 83,641,000 | 86,907,000 | 9,151,000 | 9,572,000 | 9,993,000 | 10,438,000 | 10,833,000 | 11,254,000 | 11,674,000 | 12,102,000 | 12,074,000 | 11,971,000 |
goodwill | 523,927,000 | 524,149,000 | 520,187,000 | 974,478,000 | 974,427,000 | 974,834,000 | 974,772,000 | 974,729,000 | 1,287,197,000 | 1,361,406,000 | 1,361,115,000 | 1,362,017,000 | 1,387,088,000 | 1,382,244,000 | 1,373,996,000 | 1,373,744,000 | 2,207,967,000 | 2,107,818,000 | 2,051,437,000 | 2,004,953,000 | 1,971,950,000 | 1,929,283,000 | 1,928,358,000 | 1,924,052,000 | 1,882,244,000 | 1,846,944,000 | 1,222,283,000 | 1,222,601,000 | 1,222,823,000 | 1,218,781,000 | 1,200,290,000 | 1,200,746,000 | 1,200,651,000 | 1,190,603,000 | 1,190,603,000 | 1,189,585,000 | 1,189,585,000 | 1,189,585,000 | 1,189,761,000 | 1,039,364,000 | 1,039,364,000 | 1,039,364,000 | 1,039,364,000 | 1,039,364,000 | 1,039,364,000 | 1,039,106,000 | 1,037,004,000 | 1,051,234,000 | 413,390,000 | 413,390,000 | 413,390,000 | 417,911,000 | 418,431,000 | 412,252,000 | 431,974,000 | 247,556,000 | 249,808,000 | 240,545,000 | 240,452,000 | 181,397,000 | 184,124,000 | 184,124,000 | 188,261,000 | 182,802,000 | 182,801,000 | 181,104,000 | 13,760,000 | 13,760,000 | 13,760,000 | 13,713,000 | 13,713,000 | 13,713,000 | 13,583,000 | 13,833,000 | 14,285,000 | 14,705,000 |
deferred taxes | 6,000 | 7,000 | 6,078,000 | 6,607,000 | 6,118,000 | 5,872,000 | 5,779,000 | 5,790,000 | 5,881,000 | 5,333,000 | 5,429,000 | 5,704,000 | 5,049,000 | 5,000,000 | 4,946,000 | 5,036,000 | 5,566,000 | 4,457,000 | 4,888,000 | 4,574,000 | 4,234,000 | 3,451,000 | 3,031,000 | 2,791,000 | 2,974,000 | 2,488,000 | 2,414,000 | 2,298,000 | 35,736,000 | 35,805,000 | 35,651,000 | 35,615,000 | 55,458,000 | 55,445,000 | 55,466,000 | 55,468,000 | 55,508,000 | 55,508,000 | 56,958,000 | 56,499,000 | 40,606,000 | 40,607,000 | 40,598,000 | 40,600,000 | 32,051,000 | 31,850,000 | 30,734,000 | 14,546,000 | 29,042,000 | 1,684,000 | 1,684,000 | 1,487,000 | 1,052,000 | 6,128,000 | 6,822,000 | 5,459,000 | 6,888,000 | 17,700,000 | 16,650,000 | 24,391,000 | 26,716,000 | 29,884,000 | 27,437,000 | 3,464,000 | 5,467,000 | 7,200,000 | ||||||||||
contract assets - long-term, net of allowance of 1,201 and 1,534 as of september 30, 2022 and december 31, 2021, respectively | 27,957,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
right-of-use assets - operating leases | 14,520,000 | 15,904,000 | 16,776,000 | 68,909,000 | 70,297,000 | 75,052,000 | 90,180,000 | 96,601,000 | 102,217,000 | 107,661,000 | 110,469,000 | 98,020,000 | 103,537,000 | 96,097,000 | 97,411,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 78,408,000 | 79,309,000 | 81,414,000 | 101,160,000 | 98,588,000 | 90,521,000 | 89,360,000 | 91,628,000 | 118,689,000 | 124,278,000 | 123,598,000 | 124,767,000 | 127,372,000 | 115,367,000 | 109,632,000 | 109,206,000 | 135,030,000 | 114,555,000 | 129,610,000 | 148,849,000 | 149,485,000 | 112,738,000 | 117,083,000 | 97,791,000 | 122,297,000 | 121,993,000 | 320,777,000 | 359,665,000 | 328,668,000 | 346,689,000 | 135,720,000 | 147,249,000 | 153,394,000 | 180,069,000 | 197,850,000 | 163,341,000 | 156,673,000 | 133,824,000 | 45,169,000 | 50,304,000 | 38,030,000 | 73,920,000 | 75,139,000 | 79,847,000 | 86,350,000 | 87,700,000 | 73,133,000 | 69,119,000 | 10,042,000 | 11,511,000 | 12,123,000 | 12,459,000 | 12,357,000 | 14,627,000 | 13,977,000 | 3,982,000 | 3,635,000 | 4,498,000 | 5,252,000 | 4,552,000 | 4,308,000 | 4,889,000 | 4,999,000 | 5,168,000 | 5,356,000 | 5,779,000 | 5,097,000 | 5,307,000 | 5,349,000 | 5,169,000 | 4,804,000 | 4,714,000 | 809,000 | 831,000 | 879,000 | 488,000 |
long-term assets attributable to discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total assets | 1,690,659,000 | 1,714,216,000 | 2,430,255,000 | 2,425,229,000 | 2,484,306,000 | 2,540,300,000 | 2,871,392,000 | 2,917,618,000 | 3,146,265,000 | 3,188,838,000 | 3,252,856,000 | 3,205,739,000 | 3,229,941,000 | 3,235,473,000 | 3,242,408,000 | 3,181,484,000 | 4,518,080,000 | 4,353,676,000 | 4,370,212,000 | 4,230,150,000 | 3,883,388,000 | 3,784,055,000 | 3,799,018,000 | 3,832,159,000 | 3,810,137,000 | 3,710,097,000 | 2,624,322,000 | 2,681,948,000 | 2,673,313,000 | 2,703,888,000 | 2,504,754,000 | 2,508,164,000 | 2,570,861,000 | 2,592,531,000 | 2,634,238,000 | 2,619,663,000 | 2,638,414,000 | 2,675,945,000 | 2,622,813,000 | 2,384,464,000 | 2,407,628,000 | 2,481,079,000 | 2,551,622,000 | 2,517,341,000 | 2,426,509,000 | 2,445,607,000 | 2,445,941,000 | 2,377,643,000 | 1,094,690,000 | 1,029,816,000 | 973,662,000 | 964,224,000 | 952,656,000 | 979,931,000 | 981,336,000 | 595,397,000 | 580,806,000 | 581,743,000 | 578,143,000 | 498,979,000 | 499,471,000 | 490,018,000 | 477,610,000 | 465,719,000 | 449,067,000 | 449,412,000 | 220,964,000 | 207,886,000 | 202,300,000 | 198,153,000 | 194,177,000 | 189,311,000 | 113,136,000 | 110,293,000 | 110,392,000 | 108,742,000 |
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 12,609,000 | 18,014,000 | 15,548,000 | 16,836,000 | 21,801,000 | 26,782,000 | 26,886,000 | 35,905,000 | 53,627,000 | 75,552,000 | 79,168,000 | 104,014,000 | 101,725,000 | 90,670,000 | 80,585,000 | 73,166,000 | 126,709,000 | 121,622,000 | 101,818,000 | 97,583,000 | 114,291,000 | 114,725,000 | 131,149,000 | 126,144,000 | 93,236,000 | 84,455,000 | 71,530,000 | 60,004,000 | 67,389,000 | 72,021,000 | 82,656,000 | 70,824,000 | 86,432,000 | 77,363,000 | 68,962,000 | 72,956,000 | 50,995,000 | 64,047,000 | 73,008,000 | 45,874,000 | 51,765,000 | 59,068,000 | 60,060,000 | 41,215,000 | 38,464,000 | 44,756,000 | 45,164,000 | 42,739,000 | 32,295,000 | 22,367,000 | 19,832,000 | 19,042,000 | 19,239,000 | 21,596,000 | 22,757,000 | 13,360,000 | 8,888,000 | 14,284,000 | 15,911,000 | 14,695,000 | 12,267,000 | 7,585,000 | 9,294,000 | 13,703,000 | 10,434,000 | 12,144,000 | 8,630,000 | 4,915,000 | 4,693,000 | 4,527,000 | 5,981,000 | 6,738,000 | 5,629,000 | 6,060,000 | 6,082,000 | 7,022,000 |
accrued expenses | 82,917,000 | 82,964,000 | 61,829,000 | 92,525,000 | 93,546,000 | 88,780,000 | 93,499,000 | 100,262,000 | 166,180,000 | 190,645,000 | 217,273,000 | 270,662,000 | 261,905,000 | 256,516,000 | 108,773,000 | 106,072,000 | 120,326,000 | 113,122,000 | 102,028,000 | 85,915,000 | 71,820,000 | 77,375,000 | 69,496,000 | 86,135,000 | 85,336,000 | 65,696,000 | 56,007,000 | 62,021,000 | 70,654,000 | 70,362,000 | 63,267,000 | 78,967,000 | 79,751,000 | 84,000,000 | 82,245,000 | 96,499,000 | 92,386,000 | 89,225,000 | 94,086,000 | 93,100,000 | 85,419,000 | 99,809,000 | 100,864,000 | 103,381,000 | 87,273,000 | 89,060,000 | 87,539,000 | 76,025,000 | 56,495,000 | 49,397,000 | 46,397,000 | 41,276,000 | 41,498,000 | 40,748,000 | 46,237,000 | 22,683,000 | 20,499,000 | 18,753,000 | 17,266,000 | 15,701,000 | 16,496,000 | 20,972,000 | 17,861,000 | 17,800,000 | 20,218,000 | 16,822,000 | 11,489,000 | 10,042,000 | 10,889,000 | 9,147,000 | 9,568,000 | 8,167,000 | 7,072,000 | 7,824,000 | 5,558,000 | 5,227,000 |
accrued compensation and benefits | 33,857,000 | 34,001,000 | 18,027,000 | 92,222,000 | 92,737,000 | 94,185,000 | 84,153,000 | 118,771,000 | 97,515,000 | 82,097,000 | 67,635,000 | 68,569,000 | 57,553,000 | 53,741,000 | 61,500,000 | 100,076,000 | 107,799,000 | 109,120,000 | 82,141,000 | 99,632,000 | 70,037,000 | 59,255,000 | 55,231,000 | 64,291,000 | 52,773,000 | 52,440,000 | 37,525,000 | 62,398,000 | 47,504,000 | 40,526,000 | 39,846,000 | 51,062,000 | 55,638,000 | 53,011,000 | 53,156,000 | 80,196,000 | 59,087,000 | 47,503,000 | 46,650,000 | 44,124,000 | 29,181,000 | 27,494,000 | 27,730,000 | 31,784,000 | 31,877,000 | 37,954,000 | 34,378,000 | 41,249,000 | 18,206,000 | 14,904,000 | 11,906,000 | 10,308,000 | 16,567,000 | 17,222,000 | 21,994,000 | |||||||||||||||||||||
deferred revenue | 98,930,000 | 84,882,000 | 106,491,000 | 325,900,000 | 337,884,000 | 364,000,000 | 380,355,000 | 334,764,000 | 339,239,000 | 366,378,000 | 401,483,000 | 379,843,000 | 373,105,000 | 432,222,000 | 504,089,000 | 466,797,000 | 506,568,000 | 531,189,000 | 540,289,000 | 546,830,000 | 392,462,000 | 388,647,000 | 412,620,000 | 363,772,000 | 370,821,000 | 373,543,000 | 365,415,000 | 315,925,000 | 291,251,000 | 304,456,000 | 322,111,000 | 293,022,000 | 277,243,000 | 281,467,000 | 305,602,000 | 251,038,000 | 304,055,000 | 327,363,000 | 327,863,000 | 290,653,000 | 301,125,000 | 308,503,000 | 317,564,000 | 288,900,000 | 264,936,000 | 276,532,000 | 249,233,000 | 200,420,000 | 103,984,000 | 103,719,000 | 78,583,000 | 86,564,000 | 86,032,000 | 90,878,000 | 66,012,000 | 54,325,000 | 50,614,000 | 55,589,000 | 45,940,000 | 41,084,000 | 38,613,000 | 43,562,000 | 35,549,000 | 33,732,000 | 32,967,000 | 37,459,000 | 17,306,000 | 15,103,000 | 14,444,000 | 17,097,000 | 14,607,000 | 13,759,000 | 12,418,000 | 10,353,000 | 10,959,000 | 9,245,000 |
current operating lease liabilities | 6,166,000 | 6,095,000 | 5,972,000 | 19,599,000 | 19,264,000 | 19,662,000 | 22,571,000 | 22,264,000 | 22,317,000 | 22,072,000 | 21,910,000 | 23,137,000 | 24,451,000 | 24,501,000 | 24,154,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities attributable to discontinued operations | 18,612,000 | 30,372,000 | 1,708,000 | 2,670,000 | 272,872,000 | 322,811,000 | 920,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities | 253,091,000 | 256,328,000 | 646,855,000 | 547,082,000 | 566,940,000 | 596,079,000 | 880,336,000 | 934,777,000 | 744,650,000 | 1,111,282,000 | 1,158,220,000 | 1,210,690,000 | 1,177,313,000 | 879,771,000 | 799,619,000 | 797,730,000 | 894,365,000 | 907,174,000 | 889,340,000 | 868,267,000 | 684,426,000 | 672,448,000 | 698,388,000 | 667,077,000 | 625,511,000 | 607,322,000 | 542,907,000 | 512,957,000 | 489,515,000 | 521,042,000 | 538,187,000 | 521,400,000 | 523,767,000 | 517,790,000 | 529,104,000 | 517,039,000 | 520,147,000 | 538,874,000 | 627,322,000 | 553,056,000 | 540,441,000 | 562,995,000 | 554,651,000 | 510,757,000 | 463,208,000 | 487,732,000 | 451,975,000 | 385,260,000 | 212,093,000 | 191,415,000 | 157,827,000 | 158,387,000 | 164,128,000 | 171,345,000 | 157,957,000 | 97,188,000 | 88,334,000 | 93,773,000 | 94,057,000 | 75,982,000 | 72,849,000 | 75,459,000 | 71,647,000 | 73,685,000 | 66,483,000 | 71,894,000 | 39,727,000 | 31,172,000 | 31,925,000 | 32,098,000 | 32,806,000 | 30,501,000 | 26,800,000 | 25,273,000 | 24,947,000 | 23,639,000 |
long-term debt | 200,326,000 | 199,895,000 | 377,059,000 | 350,062,000 | 373,187,000 | 421,312,000 | 169,442,000 | 167,587,000 | 1,026,048,000 | 661,703,000 | 680,434,000 | 551,004,000 | 554,864,000 | 822,724,000 | 766,240,000 | 647,539,000 | 1,002,026,000 | 983,133,000 | 1,064,305,000 | 906,725,000 | 747,441,000 | 730,028,000 | 712,676,000 | 717,853,000 | 663,089,000 | 632,699,000 | 587,388,000 | 612,405,000 | 642,348,000 | 628,933,000 | 542,399,000 | 548,682,000 | 562,519,000 | 536,899,000 | 529,755,000 | 545,133,000 | 530,545,000 | 533,451,000 | 458,601,000 | 362,697,000 | 386,793,000 | 420,921,000 | 295,205,000 | 322,664,000 | 337,557,000 | 384,327,000 | 413,769,000 | 506,500,000 | 13,995,000 | 23,995,000 | 39,995,000 | 63,699,000 | 134,938,000 | 135,014,000 | 135,089,000 | 135,162,000 | 85,234,000 | 85,304,000 | 85,373,000 | 85,441,000 | 85,508,000 | 85,573,000 | 85,637,000 | 82,500,000 | 82,500,000 | 82,500,000 | 82,500,000 | 82,500,000 | 82,500,000 | |||||||
long-term operating lease liabilities | 12,315,000 | 13,873,000 | 15,241,000 | 64,822,000 | 67,057,000 | 71,597,000 | 87,703,000 | 93,463,000 | 98,866,000 | 104,815,000 | 108,068,000 | 95,162,000 | 100,230,000 | 93,117,000 | 95,112,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other liabilities | 36,762,000 | 34,890,000 | 34,404,000 | 34,093,000 | 37,503,000 | 37,179,000 | 35,335,000 | 33,891,000 | 32,210,000 | 32,114,000 | 33,431,000 | 30,320,000 | 49,069,000 | 53,744,000 | 53,865,000 | 80,566,000 | 95,575,000 | 80,340,000 | 72,526,000 | 92,205,000 | 86,474,000 | 66,302,000 | 56,913,000 | 39,787,000 | 52,928,000 | 53,966,000 | 61,492,000 | 95,076,000 | 63,491,000 | 84,188,000 | 67,024,000 | 75,257,000 | 88,594,000 | 122,442,000 | 155,762,000 | 130,572,000 | 135,668,000 | 114,046,000 | 66,080,000 | 38,707,000 | 38,294,000 | 67,818,000 | 69,204,000 | 68,581,000 | 60,995,000 | 58,168,000 | 49,837,000 | 48,327,000 | 4,508,000 | 3,732,000 | 3,722,000 | 4,191,000 | 4,091,000 | 2,386,000 | 2,483,000 | 1,834,000 | 1,791,000 | 2,198,000 | 2,105,000 | 2,207,000 | 2,022,000 | 2,010,000 | 357,000 | 346,000 | 313,000 | 309,000 | 318,000 | 359,000 | 348,000 | 256,000 | 178,000 | 187,000 | 214,000 | 268,000 | 2,055,000 | |
long-term liabilities attributable to discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities | 513,636,000 | 517,868,000 | 1,077,149,000 | 1,017,091,000 | 1,065,719,000 | 1,146,826,000 | 1,192,734,000 | 1,251,375,000 | 1,937,878,000 | 1,945,909,000 | 2,011,076,000 | 1,920,551,000 | 1,948,883,000 | 1,919,266,000 | 1,786,291,000 | 1,601,057,000 | 2,933,420,000 | 2,756,220,000 | 2,816,408,000 | 2,638,543,000 | 2,316,313,000 | 2,208,956,000 | 2,211,394,000 | 2,171,273,000 | 2,062,228,000 | 1,991,588,000 | 1,235,055,000 | 1,262,875,000 | 1,277,735,000 | 1,312,345,000 | 1,226,667,000 | 1,223,944,000 | 1,288,035,000 | 1,293,410,000 | 1,326,618,000 | 1,301,518,000 | 1,307,380,000 | 1,308,365,000 | 1,288,522,000 | 1,100,123,000 | 1,108,508,000 | 1,200,341,000 | 1,062,078,000 | 1,040,621,000 | 987,611,000 | 1,038,000,000 | 1,018,127,000 | 1,009,160,000 | 287,865,000 | 242,589,000 | 207,923,000 | 226,656,000 | 252,286,000 | 260,489,000 | 276,401,000 | 242,137,000 | 233,355,000 | 239,296,000 | 237,503,000 | 166,689,000 | 163,469,000 | 166,136,000 | 161,360,000 | 159,539,000 | 152,369,000 | 157,840,000 | 122,545,000 | 114,031,000 | 114,773,000 | 114,854,000 | 115,484,000 | 113,188,000 | 27,014,000 | 25,541,000 | 27,002,000 | 25,681,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock: 0.01 par value... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock: 0.01 par value... | 2,794,000 | 2,790,000 | 2,776,000 | 2,766,000 | 2,766,000 | 2,766,000 | 2,751,000 | 2,745,000 | 2,744,000 | 2,743,000 | 2,733,000 | 2,725,000 | 2,724,000 | 2,724,000 | 2,719,000 | 2,709,000 | 2,708,000 | 2,707,000 | 2,706,000 | 2,693,000 | 2,692,000 | 2,691,000 | 2,690,000 | 2,680,000 | 2,679,000 | 2,678,000 | 2,672,000 | 2,665,000 | 2,662,000 | 2,661,000 | 2,655,000 | 2,651,000 | 2,648,000 | 2,648,000 | 2,641,000 | 2,635,000 | 2,631,000 | 2,626,000 | 2,618,000 | 2,571,000 | 2,561,000 | 2,560,000 | ||||||||||||||||||||||||||||||||||
treasury stock | -1,498,836,000 | -1,465,177,000 | -1,371,484,000 | -1,321,805,000 | -1,213,315,000 | -1,174,498,000 | -870,558,000 | -870,558,000 | -625,246,000 | -579,678,000 | -580,871,000 | -571,157,000 | -561,857,000 | -524,767,000 | -525,613,000 | -460,543,000 | -423,521,000 | -424,641,000 | -380,335,000 | -322,735,000 | -322,735,000 | -322,735,000 | -310,993,000 | -310,993,000 | -260,834,000 | -241,827,000 | -227,270,000 | -189,753,000 | -189,753,000 | -189,753,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -278,036,000 | -52,622,000 | -52,075,000 | -50,664,000 | -50,664,000 | -613,000 | -613,000 | ||||||||||||||||||||||||||||
additional paid-in capital | 1,923,559,000 | 1,923,805,000 | 1,922,026,000 | 1,962,386,000 | 1,952,097,000 | 1,903,542,000 | 1,906,534,000 | 1,902,776,000 | 1,929,396,000 | 1,920,645,000 | 1,914,816,000 | 1,907,348,000 | 1,876,078,000 | 1,867,613,000 | 1,858,319,000 | 1,881,494,000 | 1,765,103,000 | 1,766,863,000 | 1,770,801,000 | 1,781,059,000 | 1,782,432,000 | 1,784,247,000 | 1,784,801,000 | 1,789,959,000 | 1,790,179,000 | 1,791,838,000 | 1,794,015,000 | 1,789,449,000 | 1,782,081,000 | 1,773,464,000 | 1,754,747,000 | 1,749,593,000 | 1,745,416,000 | 1,735,199,000 | 1,727,017,000 | 1,716,847,000 | 1,708,492,000 | 1,696,980,000 | 1,639,273,000 | 1,577,260,000 | 1,567,940,000 | 1,559,563,000 | 1,549,968,000 | 1,543,167,000 | 1,528,865,000 | 1,515,479,000 | 1,499,673,000 | 1,449,946,000 | 889,738,000 | 885,876,000 | 882,868,000 | 870,487,000 | 846,257,000 | 878,430,000 | 877,237,000 | 859,739,000 | 857,887,000 | 855,203,000 | 853,402,000 | 849,628,000 | 655,980,000 | 645,541,000 | 644,004,000 | 643,537,000 | 642,503,000 | 641,415,000 | 641,280,000 | |||||||||
retained earnings | 753,392,000 | 738,864,000 | 802,890,000 | 767,556,000 | 680,281,000 | 664,101,000 | 642,175,000 | 633,118,000 | 125,289,000 | 132,842,000 | 6,792,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -3,886,000 | -3,934,000 | -3,102,000 | -2,765,000 | -3,242,000 | -2,437,000 | -2,244,000 | -1,838,000 | -3,801,000 | -5,533,000 | -7,255,000 | -4,392,000 | -5,521,000 | -4,722,000 | -4,597,000 | -5,389,000 | -5,452,000 | -4,206,000 | -2,181,000 | -1,985,000 | -2,067,000 | -2,335,000 | -134,189,000 | -61,829,000 | -12,111,000 | -22,427,000 | -3,231,000 | -4,242,000 | -3,989,000 | -2,370,000 | -3,186,000 | -1,979,000 | -1,371,000 | -622,000 | -1,704,000 | -137,000 | -766,000 | 44,000 | 144,000 | |||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 1,177,023,000 | 1,196,348,000 | 1,353,106,000 | 1,408,138,000 | 1,418,587,000 | 1,393,474,000 | 1,678,658,000 | 1,666,243,000 | 1,208,387,000 | 1,242,929,000 | 1,241,780,000 | 1,285,188,000 | 1,281,058,000 | 1,316,207,000 | 1,456,117,000 | 1,580,427,000 | 1,116,679,000 | 1,141,624,000 | 1,110,120,000 | 1,160,072,000 | 1,146,503,000 | 1,165,489,000 | 1,188,976,000 | 1,273,201,000 | 1,370,415,000 | 1,351,207,000 | 1,389,267,000 | 1,419,073,000 | 1,395,578,000 | 1,391,543,000 | 1,278,087,000 | 1,284,220,000 | 1,282,826,000 | 1,299,121,000 | 1,307,620,000 | 1,318,145,000 | 1,331,034,000 | 1,367,580,000 | 1,334,291,000 | 1,284,341,000 | 1,299,120,000 | 1,280,738,000 | 1,489,544,000 | 1,476,720,000 | 1,438,898,000 | 1,407,607,000 | 1,427,814,000 | 1,368,483,000 | 806,825,000 | 787,227,000 | 765,739,000 | 737,568,000 | 700,370,000 | 719,442,000 | 704,935,000 | 353,260,000 | 347,451,000 | 342,447,000 | 340,640,000 | 332,290,000 | 336,002,000 | 323,882,000 | 316,250,000 | 306,180,000 | 296,698,000 | 291,572,000 | 98,419,000 | 93,855,000 | 87,527,000 | 83,299,000 | 78,693,000 | 76,123,000 | 86,122,000 | 84,752,000 | 83,390,000 | 83,061,000 |
total liabilities and stockholders’ equity | 1,690,659,000 | 1,714,216,000 | 2,430,255,000 | 2,425,229,000 | 2,484,306,000 | 2,540,300,000 | 2,871,392,000 | 2,917,618,000 | 3,146,265,000 | 3,188,838,000 | 3,252,856,000 | 3,205,739,000 | 3,229,941,000 | 3,235,473,000 | 3,242,408,000 | 3,181,484,000 | 4,518,080,000 | 4,353,676,000 | 4,370,212,000 | 4,230,150,000 | 3,883,388,000 | 3,784,055,000 | 3,799,018,000 | 3,832,159,000 | 3,810,137,000 | 3,710,097,000 | 2,624,322,000 | 2,681,948,000 | 2,673,313,000 | 2,703,888,000 | 2,504,754,000 | 2,508,164,000 | 2,570,861,000 | 2,592,531,000 | 2,634,238,000 | 2,619,663,000 | 2,638,414,000 | 2,675,945,000 | 2,622,813,000 | 2,384,464,000 | 2,407,628,000 | 2,481,079,000 | 2,551,622,000 | 2,517,341,000 | 2,426,509,000 | 2,445,607,000 | 2,445,941,000 | 2,377,643,000 | 1,094,690,000 | 1,029,816,000 | 973,662,000 | 964,224,000 | 952,656,000 | 979,931,000 | 981,336,000 | 595,397,000 | 580,806,000 | 581,743,000 | 578,143,000 | 498,979,000 | 499,471,000 | 490,018,000 | 477,610,000 | 465,719,000 | 449,067,000 | 449,412,000 | 220,964,000 | 207,886,000 | 202,300,000 | 198,153,000 | 194,177,000 | 113,136,000 | 110,392,000 | 108,742,000 | ||
contract assets, net of allowance of 564 and 576 as of june 30, 2022 and december 31, 2021, respectively | 49,029,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 1,201 and 1,534 as of june 30, 2022 and december 31, 2021, respectively | 19,358,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 576 as of march 31, 2022 and december 31, 2021 | 55,162,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 1,174,747,000 | 104,782,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 1,534 as of march 31, 2022 and december 31, 2021 | 19,198,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities related to assets held for sale | 438,988,000 | 17,479,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 as of december 31, 2021 and december 31, 2020 | 124,811,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax receivable | 25,421,000 | 25,421,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 2,273 and 4,273 as of december 31, 2021 and december 31, 2020, respectively | 56,797,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 as of september 30, 2021 and december 31, 2020 | 123,244,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 as of september 30, 2021 and december 31, 2020 | 51,119,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 as of june 30, 2021 and december 31, 2020 | 120,051,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 as of june 30, 2021 and december 31, 2020 | 49,849,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 as of march 31, 2021 and december 31, 2020 | 106,945,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 as of march 31, 2021 and december 31, 2020 | 45,845,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 and 0 as of december 31, 2020 and december 31, 2019, respectively | 106,717,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 and 0 as of december 31, 2020 and december 31, 2019, respectively | 43,682,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of long-term debt | 48,293,000 | 374,538,000 | 370,751,000 | 364,465,000 | 358,574,000 | 22,121,000 | 20,518,000 | 20,059,000 | 19,516,000 | 19,509,000 | 19,503,000 | 27,687,000 | 24,550,000 | 21,413,000 | 18,277,000 | 15,158,000 | 12,051,000 | 12,077,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 and 0 as of september 30, 2020 and december 31, 2019, respectively | 101,333,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 and 0 as of september 30, 2020 and december 31, 2019, respectively | 42,805,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -94,706,000 | -95,248,000 | -87,643,000 | -251,363,000 | -228,308,000 | -319,271,000 | -338,150,000 | -354,928,000 | -337,303,000 | -194,521,000 | -187,351,000 | -190,229,000 | -190,235,000 | -188,186,000 | -190,235,000 | -206,562,000 | -201,318,000 | -198,093,000 | -188,009,000 | -185,831,000 | -160,068,000 | -142,298,000 | -121,556,000 | -100,938,000 | -51,998,000 | -29,122,000 | -17,530,000 | -2,583,000 | -10,564,000 | -16,377,000 | -40,513,000 | -61,497,000 | -77,373,000 | -83,763,000 | -100,110,000 | -118,580,000 | -556,812,000 | -557,555,000 | -558,251,000 | -558,518,000 | ||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 and 0 as of june 30, 2020 and december 31, 2019, respectively | 99,675,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 and 0 as of june 30, 2020 and december 31, 2019, respectively | 47,553,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets, net of allowance of 1,068 and 0 as of march 31, 2020 and december 31, 2019, respectively | 98,171,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term, net of allowance of 4,273 and 0 as of march 31, 2020 and december 31, 2019, respectively | 54,501,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets | 95,982,000 | 65,515,000 | 75,351,000 | 95,077,000 | 66,451,000 | 71,745,000 | 64,419,000 | 45,068,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
contract assets - long-term | 67,559,000 | 101,920,000 | 98,362,000 | 72,042,000 | 71,879,000 | 52,555,000 | 46,173,000 | 40,486,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax payable | 29,644,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(accumulated deficit) retained earnings | -49,336,000 | -30,366,000 | -24,641,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total allscripts healthcare solutions, inc.'s stockholders' equity | 1,285,188,000 | 1,281,058,000 | 1,316,207,000 | 1,456,117,000 | 1,551,113,000 | 1,087,475,000 | 1,112,415,000 | 1,071,720,000 | 1,120,882,000 | 1,105,394,000 | 1,124,565,000 | 1,147,788,000 | 1,232,466,000 | 1,329,684,000 | 1,340,027,000 | 1,378,000,000 | 1,407,884,000 | 1,384,439,000 | 1,382,684,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-controlling interest | 29,314,000 | 29,204,000 | 29,209,000 | 38,400,000 | 39,190,000 | 41,109,000 | 40,924,000 | 41,188,000 | 40,735,000 | 40,731,000 | 11,180,000 | 11,267,000 | 11,189,000 | 11,139,000 | 8,859,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of capital lease obligations | 996,000 | 9,190,000 | 9,846,000 | 9,753,000 | 7,865,000 | 8,517,000 | 8,573,000 | 9,159,000 | 9,126,000 | 9,957,000 | 7,509,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term capital lease obligations | 768,000 | 4,606,000 | 6,666,000 | 8,152,000 | 7,105,000 | 7,708,000 | 7,628,000 | 8,696,000 | 9,877,000 | 13,096,000 | 9,986,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable convertible non-controlling interest attributable to discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of non-recourse long-term debt - netsmart | 4,257,000 | 2,766,000 | 2,760,000 | 2,755,000 | 2,749,000 | 2,460,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-recourse long-term debt - netsmart | 788,489,000 | 624,549,000 | 624,872,000 | 625,193,000 | 625,513,000 | 576,427,000 | 576,673,000 | 576,918,000 | 533,589,000 | 523,381,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities attributable to discontinued operations | 2,261,000 | 4,443,000 | 14,276,000 | 21,358,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
redeemable convertible non-controlling interest - netsmart | 467,981,000 | 455,832,000 | 443,684,000 | 431,535,000 | 420,572,000 | 409,610,000 | 398,648,000 | 387,685,000 | 377,494,000 | 367,302,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets attributable to discontinued operations | 4,945,000 | 11,276,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets of disposal group held for sale | 96,478,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities of disposal group held for sale | 31,048,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
available for sale marketable securities | 63,450,000 | 74,400,000 | 149,100,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-recourse current maturities of long-term debt - netsmart | 2,456,000 | 2,451,000 | 1,337,000 | 11,602,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term marketable securities | 197,250,000 | 187,500,000 | 1,305,000 | 1,321,000 | 1,318,000 | 1,313,000 | 1,329,000 | 1,373,000 | 1,341,000 | 1,700,000 | 1,706,000 | 1,718,000 | 1,640,000 | 1,667,000 | 1,675,000 | 1,681,000 | 1,703,000 | 1,716,000 | 1,778,000 | 1,925,000 | 1,876,000 | 1,926,000 | 2,072,000 | 2,267,000 | 2,559,000 | 2,735,000 | 2,845,000 | 3,307,000 | 7,464,000 | 13,459,000 | 14,673,000 | 19,734,000 | 25,142,000 | 26,024,000 | 24,510,000 | 18,626,000 | 17,812,000 | 30,750,000 | 41,447,000 | 53,286,000 | 71,066,000 | 88,471,000 | 62,024,000 | 30,851,000 | 36,953,000 | 34,538,000 | 36,004,000 | |||||||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current maturities of long-term debt and capital lease obligations | 12,430,000 | 12,609,000 | 12,696,000 | 33,656,000 | 30,286,000 | 27,504,000 | 24,703,000 | 21,949,000 | 19,139,000 | 16,350,000 | 13,624,000 | 10,736,000 | 85,715,000 | 79,305,000 | 72,951,000 | 68,121,000 | 48,433,000 | 45,477,000 | 40,658,000 | 39,430,000 | 35,661,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | -1,745,000 | -1,115,000 | -1,992,000 | -442,000 | 76,000 | 208,000 | -542,000 | -1,325,000 | 1,762,000 | 3,602,000 | -9,000 | 210,000 | -217,000 | -256,000 | 106,000 | 102,000 | 28,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventories | 1,722,000 | 1,262,000 | 2,693,000 | 2,059,000 | 2,020,000 | 3,193,000 | 2,575,000 | 4,303,000 | 3,184,000 | 3,606,000 | 3,722,000 | 2,324,000 | 2,583,000 | 6,079,000 | 6,049,000 | 5,193,000 | 5,373,000 | 6,300,000 | 4,178,000 | 4,370,000 | 4,012,000 | 4,257,000 | 3,247,000 | 3,609,000 | 5,124,000 | 4,063,000 | 2,174,000 | 1,935,000 | 1,929,000 | 2,169,000 | 2,372,000 | 2,413,000 | 2,665,000 | 2,790,000 | 3,249,000 | 3,244,000 | ||||||||||||||||||||||||||||||||||||||||
preferred stock: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
undesignated, 0.01 par value... | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
0.01 par value... | 2,554,000 | 2,547,000 | 2,535,000 | 2,527,000 | 2,525,000 | 2,479,000 | 1,464,000 | 1,461,000 | 1,460,000 | 1,449,000 | 1,423,000 | 1,454,000 | 1,460,000 | 574,000 | 573,000 | 569,000 | 569,000 | 567,000 | 560,000 | 549,000 | 543,000 | 536,000 | 524,000 | 521,000 | 423,000 | 422,000 | 415,000 | 411,000 | 401,000 | 398,000 | 396,000 | 394,000 | 391,000 | 387,000 | ||||||||||||||||||||||||||||||||||||||||||
other current liabilities | 24,827,000 | 1,113,000 | 1,028,000 | 1,109,000 | 1,197,000 | 792,000 | 274,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income/ | 434,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
marketable securities | 5,046,000 | 5,494,000 | 5,435,000 | 11,904,000 | 10,196,000 | 5,759,000 | 28,384,000 | 26,992,000 | 20,653,000 | 14,553,000 | 11,250,000 | 14,212,000 | 13,726,000 | 54,408,000 | 56,907,000 | 44,814,000 | 34,058,000 | 22,796,000 | 15,225,000 | 5,482,000 | 4,300,000 | 3,435,000 | 5,698,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment | 19,036,000 | 18,817,000 | 13,560,000 | 12,821,000 | 12,182,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt and capital lease obligation | 901,000 | 957,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term debt and long-term capital lease obligation | 66,704,000 | 77,868,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued acquisition obligation | 8,946,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued compensation | 6,524,000 | 8,043,000 | 4,862,000 | 5,441,000 | 4,228,000 | 5,205,000 | 3,077,000 | 8,685,000 | 8,197,000 | 2,616,000 | 5,226,000 | 2,302,000 | 1,112,000 | 1,899,000 | 1,327,000 | 2,650,000 | 1,837,000 | 1,681,000 | 1,036,000 | 2,244,000 | 1,965,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 296,000 | 290,000 | 285,000 | 279,000 | 274,000 | 268,000 | 263,000 | 258,000 | 253,000 | 248,000 | 243,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less treasury stock: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
additional paid-in-capital | 850,951,000 | 858,805,000 | 852,764,000 | 844,135,000 | 838,074,000 | 835,874,000 | 654,980,000 | 651,108,000 | 649,156,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unearned compensation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other receivables | 219,000 | 150,000 | 162,000 | 502,000 | 565,000 | 671,000 | 607,000 | 627,000 | 396,000 | 313,000 | 229,000 | 237,000 | 369,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred stock-based compensation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued restructuring and other charges | 104,000 | 180,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity. | 189,311,000 | 110,293,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | 3,448,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current assets | 887,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-current liabilities | 2,042,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-05-31 | 2010-02-28 | 2009-11-30 | 2009-08-31 | 2009-05-31 | 2009-02-28 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2002-06-30 | 2002-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 14,528,000 | -64,026,000 | 22,857,000 | 87,275,000 | 16,180,000 | 21,926,000 | 9,057,000 | 727,824,000 | 542,000 | -7,605,000 | -20,354,000 | -163,632,000 | -157,907,000 | -7,977,000 | 385,896,000 | -23,846,000 | 74,272,000 | -28,515,000 | 14,863,000 | -17,462,000 | -143,011,000 | -8,565,000 | 2,882,000 | 157,000 | -2,136,000 | 2,127,000 | 16,377,000 | -5,133,000 | -3,216,000 | -10,084,000 | -2,178,000 | -25,763,000 | -17,770,000 | -20,742,000 | -20,618,000 | -48,940,000 | -22,876,000 | -11,592,000 | -24,322,000 | 9,375,000 | 7,981,000 | 5,813,000 | 24,136,000 | 20,984,000 | 15,876,000 | 12,613,000 | 15,689,000 | 18,470,000 | 15,779,000 | 12,932,000 | 13,361,000 | 4,016,000 | 2,352,000 | 80,000 | 5,944,000 | 4,124,000 | 6,028,000 | 4,467,000 | 4,483,000 | 3,262,000 | 2,827,000 | 1,323,000 | 3,403,000 | 2,940,000 | 2,033,000 | 1,334,000 | 1,403,000 | 742,000 | 696,000 | 267,000 | 116,000 | ||||
less: income from discontinued operations | 3,603,000 | -67,288,000 | 4,386,000 | -8,000 | -14,000 | 21,000 | 464,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 10,925,000 | 3,262,000 | 18,471,000 | 87,283,000 | 16,194,000 | 21,905,000 | 8,593,000 | -163,632,000 | -157,907,000 | -7,977,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 13,813,000 | 14,364,000 | 14,101,000 | 43,148,000 | 44,276,000 | 44,687,000 | 44,026,000 | 38,587,000 | 49,158,000 | 52,432,000 | 52,092,000 | 152,250,000 | 100,603,000 | 50,126,000 | -8,483,000 | 68,612,000 | 66,305,000 | 65,912,000 | 63,429,000 | 53,811,000 | 51,603,000 | 49,694,000 | 51,917,000 | 43,897,000 | 42,124,000 | 34,452,000 | 36,525,000 | 40,998,000 | 41,827,000 | 41,661,000 | 42,717,000 | 42,819,000 | 43,600,000 | 45,127,000 | 47,018,000 | 46,832,000 | 44,138,000 | 40,827,000 | 39,652,000 | 37,697,000 | 37,669,000 | 35,216,000 | 35,164,000 | 33,524,000 | 32,846,000 | 30,866,000 | 9,570,000 | 8,997,000 | 9,085,000 | 8,870,000 | 8,131,000 | 8,488,000 | 7,885,000 | 7,670,000 | 6,721,000 | 6,378,000 | 5,989,000 | 4,661,000 | 4,440,000 | 4,429,000 | 4,489,000 | 4,803,000 | 2,734,000 | 1,746,000 | 1,657,000 | 1,556,000 | 1,569,000 | 1,405,000 | 1,145,000 | 1,218,000 | 1,204,000 | 1,101,000 | 743,000 | 1,538,000 | 1,550,000 |
non-cash lease expense | -103,000 | -1,963,000 | -3,223,000 | -811,000 | -521,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | 4,553,000 | 9,024,000 | 6,324,000 | 9,308,000 | 8,777,000 | 8,383,000 | 8,701,000 | 8,105,000 | 8,811,000 | 7,166,000 | 9,954,000 | 29,563,000 | 21,790,000 | 11,658,000 | 4,828,000 | 9,848,000 | 8,010,000 | 11,952,000 | 10,629,000 | 9,679,000 | 10,515,000 | 7,946,000 | 13,160,000 | 9,660,000 | 10,138,000 | 9,919,000 | 7,438,000 | 8,908,000 | 9,197,000 | 9,120,000 | 7,051,000 | 10,055,000 | 12,078,000 | 10,070,000 | 8,416,000 | 10,484,000 | 10,106,000 | 8,004,000 | 12,663,000 | 8,807,000 | 9,929,000 | 7,727,000 | 11,597,000 | 9,934,000 | 10,474,000 | 8,747,000 | 2,838,000 | 4,261,000 | 4,424,000 | 3,326,000 | 2,618,000 | 2,103,000 | 1,679,000 | 1,613,000 | 1,959,000 | 1,018,000 | 1,510,000 | 624,000 | 656,000 | 888,000 | 617,000 | 416,000 | 407,000 | 558,000 | |||||||||||
deferred taxes | -2,511,000 | 16,575,000 | -17,042,000 | -449,000 | -1,550,000 | 1,022,000 | -1,122,000 | -6,205,000 | -202,000 | 5,292,000 | -2,160,000 | -3,066,000 | -1,506,000 | 6,000 | 9,491,000 | -5,935,000 | 5,636,000 | -5,048,000 | -50,463,000 | -665,000 | -3,089,000 | -1,570,000 | -18,423,000 | -2,638,000 | -1,198,000 | -362,000 | -4,529,000 | 3,382,000 | -110,000 | -949,000 | -6,052,000 | -839,000 | 2,437,000 | 4,398,000 | -12,343,000 | -2,898,000 | -14,559,000 | -14,080,000 | -13,731,000 | -6,101,000 | 3,714,000 | 3,338,000 | 6,971,000 | 11,637,000 | 11,892,000 | 2,895,000 | 11,093,000 | 9,793,000 | 7,385,000 | 3,291,000 | 1,390,000 | 1,294,000 | 1,007,000 | 892,000 | 2,297,000 | 3,168,000 | 2,960,000 | 2,802,000 | 2,003,000 | ||||||||||||||||
impairment of assets and long-term investments | 9,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income of unconsolidated investments | 617,000 | -22,000 | -540,000 | -154,000 | 64,000 | 270,000 | 177,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of businesses | -7,000 | 0 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | -2,264,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable and contract assets | 43,536,000 | 2,546,000 | 26,205,000 | -5,057,000 | -34,120,000 | 380,000 | 33,795,000 | -29,074,000 | 16,384,000 | 42,193,000 | 5,660,000 | 53,886,000 | 42,256,000 | 32,307,000 | -117,185,000 | -3,360,000 | -23,369,000 | 34,780,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other assets | 19,450,000 | 4,817,000 | 5,431,000 | 4,708,000 | 25,403,000 | -20,252,000 | 7,935,000 | -38,707,000 | 15,194,000 | -30,574,000 | 19,669,000 | 615,000 | -16,691,000 | 3,658,000 | -46,917,000 | -8,334,000 | 3,692,000 | -4,259,000 | 20,759,000 | 2,292,000 | -4,767,000 | -4,464,000 | 10,384,000 | 458,000 | 4,738,000 | -1,815,000 | 5,884,000 | 5,687,000 | 8,003,000 | -1,960,000 | 9,142,000 | -5,085,000 | -13,458,000 | 2,363,000 | 1,849,000 | -3,624,000 | -8,874,000 | -12,832,000 | -11,035,000 | 5,938,000 | -505,000 | -8,828,000 | -13,379,000 | -2,244,000 | -8,590,000 | -8,812,000 | -5,812,000 | -1,345,000 | -1,238,000 | 1,314,000 | 68,000 | -689,000 | 320,000 | 1,042,000 | |||||||||||||||||||||
accounts payable | -4,224,000 | 15,036,000 | 10,210,000 | -5,058,000 | -4,869,000 | -76,000 | -8,726,000 | -17,376,000 | -21,980,000 | -3,664,000 | -23,967,000 | 27,571,000 | 16,285,000 | 7,382,000 | -38,270,000 | -305,000 | 15,294,000 | 4,122,000 | -20,922,000 | 5,738,000 | -5,699,000 | 2,869,000 | 14,115,000 | 10,590,000 | -1,246,000 | 16,997,000 | -9,903,000 | -1,569,000 | -12,298,000 | 11,817,000 | -15,595,000 | 9,822,000 | 4,718,000 | -889,000 | 15,087,000 | -12,396,000 | -632,000 | 21,735,000 | -4,327,000 | -8,230,000 | 585,000 | 15,412,000 | 900,000 | -7,208,000 | 50,000 | -2,288,000 | 9,928,000 | 2,535,000 | 339,000 | 2,428,000 | 1,052,000 | 1,108,000 | -430,000 | -22,000 | -940,000 | 2,526,000 | 190,000 | -475,000 | |||||||||||||||||
accrued expenses | -11,386,000 | -591,000 | 13,031,000 | 341,000 | 3,237,000 | 23,626,000 | -5,233,000 | 500,000 | -5,537,000 | -8,049,000 | 10,022,000 | 145,450,000 | 146,841,000 | -4,847,000 | 31,667,000 | 8,458,000 | -12,900,000 | 13,259,000 | 10,827,000 | -1,009,000 | 380,000 | -5,567,000 | 10,333,000 | -134,000 | -3,544,000 | -5,165,000 | -5,185,000 | -2,861,000 | 437,000 | -15,365,000 | -647,000 | -9,619,000 | 1,754,000 | -14,255,000 | 4,429,000 | 3,349,000 | -4,714,000 | -7,616,000 | 21,313,000 | -14,259,000 | -1,054,000 | -2,603,000 | 12,804,000 | -1,815,000 | 8,602,000 | 2,707,000 | 7,096,000 | 3,001,000 | 2,518,000 | 1,666,000 | 283,000 | 3,021,000 | -549,000 | 2,066,000 | 1,462,000 | -828,000 | 2,500,000 | 552,000 | 1,462,000 | 1,075,000 | -429,000 | 444,000 | 1,407,000 | 397,000 | |||||||||||
accrued compensation and benefits | 1,294,000 | 10,076,000 | -13,291,000 | -521,000 | -900,000 | 10,020,000 | -34,633,000 | 18,828,000 | 17,061,000 | 14,339,000 | -736,000 | -43,426,000 | -47,284,000 | -39,525,000 | 18,313,000 | -3,926,000 | 20,127,000 | -21,074,000 | 16,076,000 | 8,032,000 | 3,399,000 | -5,501,000 | 8,827,000 | -1,529,000 | 13,525,000 | -24,929,000 | 14,929,000 | 7,058,000 | -594,000 | -11,136,000 | -4,648,000 | 2,312,000 | -181,000 | -27,027,000 | 21,169,000 | 11,384,000 | 80,000 | 849,000 | 14,729,000 | 2,041,000 | -331,000 | -3,338,000 | 433,000 | -5,171,000 | -4,271,000 | -5,757,000 | 3,085,000 | 2,742,000 | |||||||||||||||||||||||||||
deferred revenue | -32,909,000 | -6,804,000 | -28,352,000 | -1,830,000 | 4,466,000 | -14,853,000 | -1,475,000 | 55,487,000 | -11,449,000 | -16,095,000 | 724,000 | -138,639,000 | -77,342,000 | -17,107,000 | 117,605,000 | -26,663,000 | -11,613,000 | -21,319,000 | 107,380,000 | -6,262,000 | -23,764,000 | 48,687,000 | -8,865,000 | -7,036,000 | -11,770,000 | 49,393,000 | 23,132,000 | -12,828,000 | -19,172,000 | 29,240,000 | 12,377,000 | -12,009,000 | -21,507,000 | 54,248,000 | -24,742,000 | -13,436,000 | 1,143,000 | 35,462,000 | -11,165,000 | -6,102,000 | -8,089,000 | 28,570,000 | 24,887,000 | -7,715,000 | 26,147,000 | 29,409,000 | 405,000 | 25,136,000 | -7,981,000 | 532,000 | -4,723,000 | 7,133,000 | -4,975,000 | 9,649,000 | 2,846,000 | 2,471,000 | -4,949,000 | 8,013,000 | 3,313,000 | 2,203,000 | 2,490,000 | 848,000 | 1,341,000 | 2,065,000 | -606,000 | ||||||||||
other liabilities | -860,000 | -22,820,000 | 2,022,000 | -3,409,000 | 326,000 | 1,844,000 | 1,444,000 | 3,624,000 | 95,000 | -1,318,000 | 2,933,000 | -701,000 | -2,670,000 | 1,380,000 | 13,879,000 | -831,000 | -3,844,000 | 2,887,000 | 1,650,000 | 6,211,000 | 7,680,000 | -997,000 | -1,085,000 | -1,134,000 | 1,052,000 | 54,000 | 907,000 | -1,258,000 | 215,000 | -47,000 | -1,556,000 | -72,000 | -1,044,000 | -4,353,000 | -7,396,000 | -3,115,000 | -4,775,000 | -576,000 | 1,670,000 | 92,000 | -335,000 | 929,000 | -1,196,000 | 939,000 | -1,038,000 | 605,000 | 231,000 | -51,000 | -29,000 | -41,000 | 27,000 | 91,000 | 79,000 | -27,000 | -54,000 | 13,000 | |||||||||||||||||||
net cash from operating activities - continuing operations | 42,341,000 | 42,149,000 | 34,511,000 | 66,317,000 | 56,868,000 | 69,244,000 | 55,911,000 | -59,572,000 | 52,967,000 | 22,646,000 | -3,708,000 | 63,944,000 | 28,090,000 | 35,816,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities - discontinued operations | -14,200,000 | -43,784,000 | 34,750,000 | -1,273,000 | -978,000 | -270,181,000 | -51,336,000 | -30,000,000 | -30,000,000 | -30,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 28,141,000 | -1,635,000 | 69,261,000 | 65,044,000 | 55,890,000 | -200,937,000 | 4,575,000 | -178,620,000 | 52,967,000 | 22,646,000 | -3,708,000 | 33,944,000 | -1,910,000 | 5,816,000 | -13,663,000 | 15,014,000 | 8,232,000 | 58,308,000 | 106,232,000 | 63,824,000 | 33,882,000 | 75,477,000 | 83,846,000 | 53,059,000 | 56,166,000 | 75,933,000 | 83,266,000 | 39,504,000 | 30,279,000 | 58,530,000 | 51,493,000 | 13,729,000 | 16,986,000 | 21,288,000 | 17,676,000 | 12,515,000 | 11,430,000 | 39,366,000 | 58,122,000 | 31,108,000 | 58,846,000 | 74,594,000 | 107,429,000 | 42,178,000 | 52,253,000 | 66,894,000 | 52,297,000 | 46,521,000 | 19,833,000 | 21,267,000 | 28,889,000 | 6,679,000 | 7,428,000 | 14,930,000 | 22,002,000 | 1,599,000 | -4,293,000 | 11,209,000 | 11,614,000 | 4,049,000 | 2,514,000 | 9,236,000 | 10,833,000 | -408,000 | 3,181,000 | 2,901,000 | 4,157,000 | 3,382,000 | 2,531,000 | 2,377,000 | 1,319,000 | 14,537,000 | -2,749,000 | -7,902,000 | |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital expenditures | -224,000 | -1,307,000 | -345,000 | -744,000 | -1,457,000 | -717,000 | -2,377,000 | -9,129,000 | -3,036,000 | -2,015,000 | -2,845,000 | -13,475,000 | -9,429,000 | -4,847,000 | -4,639,000 | -10,057,000 | -8,011,000 | -8,602,000 | -6,160,000 | -15,181,000 | -10,511,000 | -14,524,000 | -10,464,000 | -8,414,000 | -8,880,000 | -7,752,000 | -4,111,000 | -4,596,000 | -3,500,000 | -6,115,000 | -5,782,000 | -3,385,000 | -5,326,000 | -11,945,000 | -17,142,000 | -11,338,000 | -29,215,000 | -16,435,000 | -24,685,000 | -16,749,000 | -19,309,000 | -19,423,000 | -11,005,000 | -12,123,000 | -9,394,000 | -11,784,000 | 0 | -3,254,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -323,000 | -474,000 | -308,000 | 0 | 0 | -782,000 | -290,000 | |
free cash flows | 27,917,000 | -2,942,000 | 68,916,000 | 64,300,000 | 54,433,000 | -201,654,000 | 2,198,000 | -187,749,000 | 49,931,000 | 20,631,000 | -6,553,000 | 20,469,000 | -11,339,000 | 969,000 | -18,302,000 | 4,957,000 | 221,000 | 49,706,000 | 100,072,000 | 48,643,000 | 23,371,000 | 60,953,000 | 73,382,000 | 44,645,000 | 47,286,000 | 68,181,000 | 79,155,000 | 34,908,000 | 26,779,000 | 52,415,000 | 45,711,000 | 10,344,000 | 11,660,000 | 9,343,000 | 534,000 | 1,177,000 | -17,785,000 | 22,931,000 | 33,437,000 | 14,359,000 | 39,537,000 | 55,171,000 | 96,424,000 | 30,055,000 | 42,859,000 | 55,110,000 | 52,297,000 | 43,267,000 | 19,833,000 | 21,267,000 | 28,889,000 | 6,679,000 | 7,428,000 | 14,930,000 | 22,002,000 | 1,599,000 | -4,293,000 | 11,209,000 | 11,614,000 | 4,049,000 | 2,514,000 | 9,236,000 | 10,833,000 | -408,000 | 3,181,000 | 2,901,000 | 4,157,000 | 3,059,000 | 2,057,000 | 2,069,000 | 1,319,000 | 14,537,000 | -3,531,000 | -8,192,000 | |
capitalized software | -7,949,000 | -8,658,000 | -9,600,000 | -17,783,000 | -20,010,000 | -17,328,000 | -18,144,000 | -9,961,000 | -22,755,000 | -26,721,000 | -28,556,000 | -86,190,000 | -55,222,000 | -28,600,000 | -12,036,000 | -32,285,000 | -36,760,000 | -32,227,000 | -31,816,000 | -35,497,000 | -37,571,000 | -34,011,000 | -32,478,000 | -32,888,000 | -21,972,000 | -15,134,000 | -16,568,000 | -11,012,000 | -12,369,000 | -9,315,000 | -12,343,000 | -10,269,000 | -8,905,000 | -9,144,000 | -11,564,000 | -10,946,000 | -11,645,000 | -7,871,000 | -3,625,000 | -12,404,000 | -13,668,000 | -13,268,000 | -14,219,000 | -16,206,000 | -14,002,000 | -16,321,000 | -4,922,000 | ||||||||||||||||||||||||||||
cash paid for business acquisitions, net of cash acquired | 0 | 0 | -24,106,000 | -23,443,000 | -11,718,000 | 166,640,000 | -164,832,000 | -70,021,000 | -109,020,000 | -168,002,000 | -50,333,000 | 0 | -3,975,000 | -59,596,000 | -29,740,000 | 0 | 0 | 0 | -73,000 | -148,802,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of businesses and other investments, net of cash divested, and distributions received | 10,000 | 671,405,000 | 1,083,000 | 61,225,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of equity securities, other investments and related intangible assets | -1,091,000 | 0 | -2,200,000 | 0 | -221,000 | -7,191,000 | -1,159,000 | -14,211,000 | 0 | -183,000 | -4,100,000 | -500,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities - continuing operations | -9,254,000 | 661,189,000 | -32,968,000 | 42,698,000 | -20,328,000 | -15,556,000 | -18,989,000 | -130,285,000 | -77,519,000 | -33,410,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities - discontinued operations | 0 | -4,017,000 | -11,231,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -9,254,000 | 657,172,000 | -44,199,000 | 42,698,000 | -20,328,000 | -15,556,000 | -18,989,000 | 1,680,120,000 | -24,226,000 | -6,277,000 | -34,429,000 | -130,285,000 | -77,519,000 | -33,410,000 | 481,334,000 | -212,803,000 | 129,294,000 | -149,812,000 | -206,161,000 | -104,896,000 | -49,405,000 | -52,510,000 | -103,038,000 | -71,042,000 | -956,551,000 | -23,375,000 | -23,811,000 | -15,717,000 | -234,570,000 | -14,868,000 | -18,115,000 | -41,270,000 | -22,320,000 | -26,983,000 | -28,670,000 | -22,273,000 | -40,605,000 | -160,592,000 | -28,300,000 | -29,110,000 | -32,951,000 | -32,676,000 | -25,212,000 | -28,318,000 | -12,084,000 | -30,060,000 | -8,111,000 | 11,884,000 | -2,035,000 | 4,861,000 | 3,298,000 | -43,244,000 | 2,767,000 | -4,792,000 | 1,811,000 | -6,046,000 | |||||||||||||||||||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
taxes paid related to net share settlement of equity awards | -4,795,000 | -14,596,000 | -13,275,000 | -56,000 | -80,000 | -7,915,000 | -5,972,000 | -444,000 | -56,000 | -2,359,000 | -3,174,000 | -6,762,000 | -6,695,000 | -5,327,000 | -703,000 | -153,000 | -114,000 | -8,496,000 | -492,000 | -223,000 | -690,000 | -5,864,000 | -825,000 | -16,000 | -3,217,000 | -4,146,000 | -1,348,000 | -181,000 | -3,326,000 | -2,207,000 | -1,509,000 | -329,000 | -5,378,000 | -3,184,000 | -1,848,000 | -1,224,000 | -5,012,000 | -1,648,000 | -5,940,000 | -731,000 | -1,323,000 | -2,298,000 | -9,277,000 | ||||||||||||||||||||||||||||||||
credit facility payments | 0 | -175,000,000 | -25,000,000 | -25,000,000 | -1,140,000,000 | -7,500,000 | -87,500,000 | -80,000,000 | -15,000,000 | -10,000,000 | -5,000,000 | -453,273,000 | -43,044,000 | -216,217,000 | -1,217,000 | -27,467,000 | -4,342,000 | -24,213,000 | -86,726,000 | -76,738,000 | -29,145,000 | -23,198,000 | -28,164,000 | -48,599,000 | -148,629,000 | -20,658,000 | -20,625,000 | -23,125,000 | -10,625,000 | -32,813,000 | -30,313,000 | -35,312,000 | -2,814,000 | -543,853,000 | -27,614,000 | -17,615,000 | -29,214,000 | -179,523,000 | -24,522,000 | -9,928,000 | -45,491,000 | -25,490,000 | -89,515,000 | -10,000,000 | |||||||||||||||||||||||||||||||
credit facility borrowings, net of issuance costs | 0 | -2,665,000 | 25,000,000 | 0 | 0 | 230,000,000 | 388,625,000 | 75,000,000 | 210,000,000 | 249,241,000 | 180,000,000 | 120,000,000 | -66,650,000 | 221,650,000 | 130,000,000 | 145,843,000 | 185,000,000 | 69,698,000 | 40,000,000 | 80,000,000 | 169,400,000 | 55,000,000 | 10,000,000 | 36,964,000 | 40,000,000 | 15,000,000 | 50,000,000 | 0 | 281,940,000 | 129,043,000 | -25,000 | -150,000 | 0 | -169,000 | 0 | 47,362,000 | |||||||||||||||||||||||||||||||||||||||
repurchase of common stock | -33,659,000 | -93,693,000 | -49,679,000 | -108,490,000 | -200,000,000 | -79,581,000 | -45,568,000 | 0 | -9,714,000 | -102,160,000 | -65,070,000 | -65,070,000 | -37,023,000 | 0 | -44,306,000 | -57,599,000 | 0 | 0 | -50,159,000 | -19,007,000 | -14,558,000 | -37,517,000 | 0 | 0 | -225,414,000 | -547,000 | -1,411,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
intercompany to/from parent/subsidiaries | 0 | 0 | 11,685,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of acquisition and other financing obligations | 0 | 0 | -858,000 | -1,542,000 | 0 | 0 | -1,458,000 | -2,911,000 | -11,473,000 | -1,473,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities - continuing operations | -38,454,000 | -285,954,000 | -51,269,000 | 50,373,000 | 42,630,000 | -9,516,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities - discontinued operations | 0 | 0 | -11,697,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | -38,454,000 | -285,954,000 | -62,966,000 | -133,546,000 | -50,080,000 | -67,726,000 | -7,514,000 | -1,190,025,000 | -9,499,000 | 50,373,000 | 42,630,000 | -9,516,000 | -402,371,000 | 176,841,000 | -140,166,000 | 72,713,000 | 152,939,000 | 61,182,000 | 69,000 | -15,605,000 | 39,300,000 | 4,702,000 | 891,133,000 | -69,864,000 | -33,954,000 | -8,104,000 | 192,181,000 | -7,858,000 | -17,181,000 | 25,911,000 | 2,792,000 | -15,802,000 | 13,280,000 | -1,659,000 | 11,128,000 | 109,184,000 | -19,383,000 | -29,611,000 | -80,427,000 | -25,483,000 | -9,201,000 | -43,054,000 | -69,938,000 | -21,446,000 | -11,299,000 | -33,035,000 | -12,451,000 | 396,000 | 1,374,000 | 293,000 | 51,466,000 | 732,000 | 5,432,000 | 2,491,000 | 4,614,000 | 5,453,000 | 1,789,000 | 122,418,000 | 469,000 | 3,383,000 | 3,475,000 | 2,091,000 | 1,455,000 | 68,851,000 | 1,037,000 | 1,083,000 | 299,000 | ||||||||
effect of exchange rate changes on cash and cash equivalents | 0 | -717,000 | -11,000 | 4,000 | -545,000 | 92,000 | -27,000 | 1,080,000 | 470,000 | 375,000 | -713,000 | -103,000 | 143,000 | 163,000 | -296,000 | -37,000 | -356,000 | 65,000 | 64,000 | 200,000 | 177,000 | 419,000 | -749,000 | -123,000 | -209,000 | 549,000 | -26,000 | -822,000 | 167,000 | -497,000 | -369,000 | -275,000 | 212,000 | 123,000 | -122,000 | 223,000 | -2,197,000 | 314,000 | -155,000 | 912,000 | |||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | -19,567,000 | -25,800,000 | -15,063,000 | -284,127,000 | -21,955,000 | 312,555,000 | 19,712,000 | -6,934,000 | 74,593,000 | 65,004,000 | -18,726,000 | 53,074,000 | 7,781,000 | 19,359,000 | -13,404,000 | -9,461,000 | -16,757,000 | 25,475,000 | 14,861,000 | -11,943,000 | 35,307,000 | -20,244,000 | -11,728,000 | 17,927,000 | 72,975,000 | -30,893,000 | -29,775,000 | 16,043,000 | 27,653,000 | 27,111,000 | 3,797,000 | 13,690,000 | 1,300,000 | 969,000 | 20,345,000 | 1,760,000 | 23,186,000 | 940,000 | 11,517,000 | 8,290,000 | -30,356,000 | 28,989,000 | 6,335,000 | -1,332,000 | |||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, beginning of period | 0 | 0 | 190,520,000 | 0 | 0 | 0 | 537,465,000 | 0 | 0 | 0 | 137,539,000 | 184,795,000 | 184,795,000 | 184,795,000 | 0 | 0 | 0 | 162,498,000 | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period | -19,567,000 | 368,866,000 | 152,605,000 | -25,800,000 | -15,063,000 | -284,127,000 | 515,510,000 | 312,555,000 | 19,712,000 | -6,934,000 | 212,132,000 | 138,724,000 | 148,139,000 | 147,848,000 | 65,004,000 | -20,985,000 | -2,996,000 | 143,772,000 | 53,074,000 | 20,310,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents attributable to discontinued operations | 12,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period, excluding discontinued operations | -7,567,000 | 138,724,000 | 148,139,000 | 147,848,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other (income) loss | -5,111,000 | -732,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net income (income) of unconsolidated investments | 398,000 | 257,000 | 61,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other loss | 226,000 | 2,031,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -37,915,000 | -46,071,000 | -36,656,000 | -36,947,000 | 15,828,000 | -1,905,000 | -2,330,000 | -21,374,000 | -26,701,000 | -973,000 | -12,007,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents and restricted cash included in current assets held for sale | -68,518,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash, end of period, excluding current assets held for sale | 84,087,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued doj settlement | -58,424,000 | -15,725,000 | -15,731,000 | -57,289,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other proceeds from investing activities | 14,000 | 9,000 | 5,000 | -10,000 | 19,000 | 8,000 | 37,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of 0.875% convertible senior notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for issuance costs on 0.875% convertible senior notes | 0 | 0 | 0 | -758,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for capped call transaction on 0.875% convertible senior notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayment of convertible senior notes | 0 | -345,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of subsidiary shares owned by non-controlling interest | -54,064,000 | -54,064,000 | -54,064,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment charges | 74,759,000 | 4,037,000 | 3,789,000 | 98,000 | 28,091,000 | 0 | 0 | 0 | 0 | 4,650,000 | 1,203,000 | 22,000 | 293,000 | 26,000 | 256,000 | 188,000 | 1,751,000 | 195,000 | 950,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of long-term investments | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received from sale of businesses, net of cash divested | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of other investments | 166,000 | 1,753,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
distributions received from investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accelerated share repurchase program | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating right-of-use asset amortization | 5,019,000 | 4,571,000 | 5,277,000 | 5,241,000 | 5,631,000 | 16,722,000 | 11,007,000 | 5,320,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other loss (income) | 1,752,000 | 287,000 | 2,796,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating leases | -4,143,000 | -4,157,000 | -4,782,000 | -4,153,000 | -6,174,000 | -17,897,000 | -11,874,000 | -5,854,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill impairment charge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale or issuance of common stock | 0 | 1,071,000 | 0 | 212,000 | 0 | 79,000 | 0 | 5,000 | 1,540,000 | 659,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment (recovery) of long-term investments | 1,025,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in net (income) loss of unconsolidated investments | -383,000 | -115,000 | -449,000 | 28,000 | -285,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales (purchases) of equity securities, other investments and related intangible assets | 1,565,000 | 32,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of unsettled common stock | -9,301,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
recovery of long-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(purchases) sales of equity securities, other investments and related intangible assets | -3,028,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided (used in) by financing activities | 113,443,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash received from sale of businesses | 566,611,000 | -5,648,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents within current assets attributable to discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
software development costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: accumulated amortization | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(recovery) impairment of long-term investments | -1,045,000 | -1,045,000 | -1,045,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of lease obligations | -108,000 | -68,000 | -55,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
less: cash and cash equivalents included in current assets attributable to discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenue related to deferred revenue balance at beginning of period | 126,184,000 | 126,184,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenue related to new performance obligations satisfied during the period | 248,221,000 | 248,221,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
revenue recognized under "right-to-invoice" expedient | 55,923,000 | 55,923,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reimbursed travel expenses, shipping and other revenue | 1,721,000 | 1,721,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total revenue | 432,049,000 | 432,049,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other (income) losses | 1,992,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of businesses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income (losses) | 172,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of acquisition financing obligations | -1,419,000 | 0 | 0 | -3,226,000 | -2,480,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other (losses) income | -8,978,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
excess tax benefits from stock-based compensation | -42,000 | -10,000 | -765,000 | -197,000 | -298,000 | -13,000 | -331,000 | -2,000 | -28,000 | -1,086,000 | -1,132,000 | -591,000 | -803,000 | -839,000 | -1,654,000 | -2,907,000 | -508,000 | 0 | -101,000 | -4,130,000 | 2,363,000 | -2,875,000 | -4,176,000 | 11,839,000 | 1,269,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
payments of capital lease obligations | 7,518,000 | -2,683,000 | -2,584,000 | -2,804,000 | -3,190,000 | -3,047,000 | -2,951,000 | -3,015,000 | -2,419,000 | -2,220,000 | -1,399,000 | -239,000 | -287,000 | -174,000 | -69,000 | -68,000 | -118,000 | -114,000 | -113,000 | -110,000 | -42,000 | -116,000 | -118,000 | -182,000 | -187,000 | -204,000 | -199,000 | -232,000 | -353,000 | -356,000 | -352,000 | -366,000 | -303,000 | -23,000 | 2,000 | -7,000 | |||||||||||||||||||||||||||||||||||||||
write-off of unamortized deferred debt issuance costs - netsmart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(purchases) sales of subsidiary shares owned by non-controlling interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other losses | -415,000 | 50,000 | 294,000 | 1,417,000 | 1,054,000 | 1,240,000 | 1,094,000 | 5,405,000 | 3,059,000 | 631,000 | 1,238,000 | 85,000 | 965,000 | 1,612,000 | -335,000 | 1,044,000 | 86,000 | 828,000 | 454,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of and losses on long-term investments | 5,500,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of unamortized deferred debt issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | -68,175,000 | -18,209,000 | -5,037,000 | -8,010,000 | -5,103,000 | -316,000 | -157,000 | -12,250,000 | -3,845,000 | -4,127,000 | 5,943,000 | 5,244,000 | 7,643,000 | 1,090,000 | 4,801,000 | -28,178,000 | -18,671,000 | 16,871,000 | 5,000,000 | -10,905,000 | 34,267,000 | -7,948,000 | 11,957,000 | -12,103,000 | 5,958,000 | -17,466,000 | -39,215,000 | -5,189,000 | -27,380,000 | -6,417,000 | 3,908,000 | -1,855,000 | -1,552,000 | 982,000 | -2,561,000 | 7,095,000 | -1,508,000 | -2,175,000 | |||||||||||||||||||||||||||||||||||||
proceeds from issuance of redeemable convertible preferred stock - netsmart | -1,000 | 1,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of subsidiary shares to non-controlling interest | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds received from sale of fixed assets | 0 | 0 | 26,000 | 11,000 | 0 | 0 | 8,000 | 7,000 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of period | 96,610,000 | 0 | 0 | 0 | 116,873,000 | 0 | 0 | 0 | 53,173,000 | 0 | 0 | 0 | 62,954,000 | 0 | 0 | 0 | 103,956,000 | 0 | 0 | 0 | 157,753,000 | 0 | 0 | 0 | 129,403,000 | 0 | 0 | 71,159,000 | 0 | 0 | 0 | 43,785,000 | 0 | 0 | 42,461,000 | 0 | 0 | 60,905,000 | 0 | 0 | 16,972,000 | 0 | 0 | 13,336,000 | -16,877,000 | 0 | 34,124,000 | ||||||||||||||||||||||||||||
cash and cash equivalents, end of period | 104,391,000 | 19,359,000 | -13,404,000 | -9,461,000 | 100,116,000 | 25,475,000 | 14,861,000 | -11,943,000 | 88,480,000 | 15,828,000 | -1,905,000 | -2,330,000 | 41,580,000 | 2,164,000 | -11,194,000 | -20,244,000 | 92,228,000 | 10,284,000 | -26,701,000 | -55,307,000 | 175,680,000 | 72,975,000 | -30,893,000 | -29,775,000 | 145,446,000 | 27,111,000 | 3,797,000 | 84,849,000 | 969,000 | 20,345,000 | 7,123,000 | 43,721,000 | -8,408,000 | -3,845,000 | 44,221,000 | 2,756,000 | -2,247,000 | 35,225,000 | 940,000 | 11,517,000 | 25,262,000 | 28,989,000 | 6,335,000 | 12,004,000 | -10,648,000 | -973,000 | 22,117,000 | ||||||||||||||||||||||||||||
supplemental non-cash information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accretion of redemption preference on redeemable convertible non-controlling interest in netsmart | 10,962,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
obligations to enter into capital leases | 1,407,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other losses (gains) | 858,000 | 949,000 | 1,407,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales and maturities of marketable securities and other investments | 0 | 2,458,000 | 0 | 1,305,000 | 10,000 | 43,000 | 26,000 | 15,000 | 12,000 | 11,000 | -9,000 | 41,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
exchange of netsmart, inc. common stock for redeemable convertible preferred stock in netsmart by netsmart, inc. management | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of controlling interest, net of cash acquired | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of non-marketable securities, other investments and related intangible assets | -500,000 | -3,132,000 | -2,567,000 | -209,337,000 | -750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
credit facility borrowings | 14,442,000 | 140,208,000 | 114,511,000 | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance 1.25% senior cash convertible notes, net of issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of call option related to 1.25% senior cash convertible notes | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of warrants, net of issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments of acquisition financing obligations | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 40,000 | -183,000 | -13,000 | 10,000 | 1,673,000 | 191,000 | 1,992,000 | 1,333,000 | 7,931,000 | 1,477,000 | 180,000 | 1,847,000 | 2,015,000 | -5,000 | 1,992,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of business combinations: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities, other investments and related intangible assets | 0 | -7,470,000 | -8,106,000 | -5,968,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales and maturities of other investments | 10,000 | 10,000 | 19,000 | 36,000 | 11,000 | 328,000 | 12,516,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of fixed assets | 24,000 | 7,000 | 55,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in fair value of 1.25% call option and cash conversion option | 56,000 | 42,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities and other investments | 0 | 0 | -8,679,000 | -4,221,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in restricted cash | 0 | 0 | 0 | 2,225,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other (gains) losses | -8,256,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of 1.25% senior cash convertible notes, net of issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of warrants, net of issuance cost | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of business combinations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash acquired in merger with eclipsys | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventories | -460,000 | 1,391,000 | -634,000 | -39,000 | 1,173,000 | -619,000 | 1,242,000 | 116,000 | -1,398,000 | 259,000 | 362,000 | 475,000 | -239,000 | -6,000 | 240,000 | 203,000 | 41,000 | 252,000 | 125,000 | 459,000 | 33,000 | -1,178,000 | 945,000 | 939,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 5,110,000 | 2,495,000 | 2,789,000 | 2,774,000 | 2,001,000 | 1,943,000 | 3,162,000 | 1,801,000 | 879,000 | 1,290,000 | 1,188,000 | 663,000 | 2,046,000 | 1,014,000 | 817,000 | 410,000 | 559,000 | 818,000 | 857,000 | 852,000 | 1,147,000 | 324,000 | 202,000 | -79,000 | 328,000 | 102,000 | 276,000 | 298,000 | -105,000 | -18,000 | 138,000 | ||||||||||||||||||||||||||||||||||||||||||||
effect of exchange rates on cash and cash equivalents | 1,492,000 | -41,000 | -1,699,000 | -6,000 | 655,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment losses | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on sale of prepackaged medications business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for acquisition of allscripts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash acquired in merger with allscripts | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds received from sale of building | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds received from sale of prepackaged medications business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on promissory note | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit payments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
line of credit borrowings | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in parent’s net investment, including 330,000 received from misys plc | 5,302,000 | 5,246,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of senior convertible notes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from stock-based compensation activities | 6,825,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from employee stock purchase plan | 679,000 | 635,000 | 559,000 | 330,000 | 500,000 | 329,000 | 566,000 | 423,000 | 214,000 | 180,000 | 175,000 | 224,000 | 195,000 | 203,000 | 267,000 | 172,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds received from sale of fixed assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds (payments) from stock-based compensation activities | 16,338,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other gains | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities | -5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the sale of the prepackaged medications business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of common stock options | 252,000 | -227,000 | 1,033,000 | 811,000 | 3,830,000 | 536,000 | 182,000 | 1,194,000 | 118,000 | 5,229,000 | 2,224,000 | 4,442,000 | 5,310,000 | 2,105,000 | 2,520,000 | 24,000 | 1,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
change in parent’s net investment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of preferred shares in imedica | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, beginning of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents, end of year | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sales and maturities of marketable securities | 70,000 | 172,000 | 4,185,000 | 7,062,000 | 1,505,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of marketable securities | -41,776,000 | -2,200,000 | -16,935,000 | -5,585,000 | -14,091,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued compensation | -1,519,000 | 487,000 | 5,581,000 | 813,000 | 156,000 | 645,000 | -1,208,000 | 623,000 | -1,044,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for other acquisitions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment loss | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventory | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other non-current liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for acquisition of allscripts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment on promissory note | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of capital lease obligation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of credit facility | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from continuing operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income from discontinued operations, net of tax | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of equity investment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
realized loss on investments | 1,000 | 7,000 | 5,000 | 6,000 | 23,000 | 12,000 | 8,000 | 8,000 | 118,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of physicians interactive business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of equity investment | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net payments for purchase of extended care information network, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net payments for purchase of a4 health systems, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net payments for other acquisitions and related transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of physicians interactive business | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
maturities of marketable securities | 2,406,000 | 1,479,000 | 26,739,000 | 3,670,000 | 7,469,000 | 3,904,000 | 9,690,000 | 8,394,000 | 2,277,000 | 53,665,000 | 19,733,000 | 12,596,000 | 9,616,000 | 9,927,000 | 16,906,000 | 889,000 | 6,731,000 | 13,773,000 | 17,797,000 | 26,827,000 | 8,816,000 | 8,441,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net payments for purchase of extended care information systems, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of capitalized software | 0 | 0 | 0 | 290,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
realized (gain) loss on investments | 8,000 | 20,000 | 14,000 | 9,000 | 41,000 | -113,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capitalized software and website development costs | -934,000 | -1,151,000 | -1,322,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in promissory note receivable and minority interest | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of equity investment. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net payments for purchase of a4 health sytems, inc. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds received in issuance of common stock | 0 | 1,000 | -317,000 | 140,991,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of common stock from a related party | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from revolving credit facility | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in promissory note receivable | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for a4 health systems, inc. and related transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for other acquisitions and related transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from exercise of common stock options | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash investing and financing information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock issued in connection with the acquisition of a4 health systems, inc. | 0 | 0 | 68,775,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assumption of secured promissory note in connection with the a4 acquisition | 0 | 0 | 3,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock from treasury | 11,250,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued restructuring and other charges | -75,000 | -317,000 | -866,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for a4 health systems, inc. and related transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
debt issuance costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of convertible debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of treasury stock | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other receivables | -69,000 | 12,000 | 340,000 | 63,000 | 20,000 | -83,000 | -84,000 | 8,000 | 132,000 | 865,000 | 147,000 | -634,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment for purchase of a4 health systems, inc. and related transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of common stock from related party | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of interest on long term debt | 1,444,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for acquisitions | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of stock options | 3,417,000 | 1,958,000 | 3,623,000 | 472,000 | 1,035,000 | 1,090,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of interest on long-term debt | 1,444,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of state income taxes | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restructuring and other charges | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash compensation expense | 0 | -86,000 | 82,000 | 82,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
realized gain on investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of effects of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments for acquisitions, net of cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of transaction costs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of acquired in-process research and development | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment charge | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capitalized software development costs | -638,000 | -106,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of common stock options and warrants | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of effects of acquisitions: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current and non-current assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid during the period for interest | -7,000 | 13,000 | 15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -3,962,000 | -6,024,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | 209,000 | 202,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid and other current and non-current assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from acquisitions, net of acquired cash | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of capital lease obligations | -54,000 | -52,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided (used) by financing activities | -35,000 | 1,941,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of common stock and options in acquisitions | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid and other current assets | 542,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses and deferred revenue | 2,000 |